Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 638.00
Bid: 632.00
Ask: 650.00
Change: 4.00 (0.63%)
Spread: 18.00 (2.848%)
Open: 618.00
High: 650.00
Low: 618.00
Prev. Close: 634.00
PRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Change

26 Jun 2023 07:00

RNS Number : 7885D
Porvair PLC
26 June 2023
 

For immediate release 26 June 2023

 

 

Porvair plc

("Porvair" or the "Group" or the "Company")

 

Board change

 

Porvair is pleased to announce the appointment of Sarah Vawda as an independent Non-Executive Director of the Company with effect from 26 June 2023.

Sarah is the Senior Independent Non-Executive Director and Chair of the Audit Committee of Access Intelligence plc, an AIM listed reputation management, marketing and communications, software as a service business; Non-Executive Director of Hamlet Protein A/S, a private equity backed Danish specialty protein business; and Non-Executive Director and Chair of the Remuneration and Nomination Committees of Noveltech Private Feeds Ltd (India), a private equity backed Indian animal nutrition business. She was formerly Non-Executive Director and Chair of the Audit and Risk Committees at Burger King UK; Trustee and Chair of the Audit Committee at The Girls Network; and Governor of the University of Bedfordshire.

Sarah has previously held senior executive roles within Global multinational companies including Powergen Plc, Corus Group plc, Christian Salvesen plc, Provimi SA and Johnson Matthey plc. She qualified as a chartered accountant with PwC.

On appointment, Sarah will join the Audit Committee, Remuneration Committee and Nominations Committee of Porvair plc.

Porvair confirms that there are no further matters in relation to Sarah Vawda's appointment to be disclosed pursuant to the requirements of paragraph 9.6.13 of the Listing Rules of the UK Listing Authority.

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Company Secretary

Buchanan Communications

0207 466 5000

Charles Ryland / Simon Compton / Jack Devoy

 

Notes to Editors

Porvair is a group of specialist filtration, laboratory and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFIERAIVFIV
Date   Source Headline
26th Jan 201512:30 pmRNSDirector Declaration
26th Jan 20157:00 amRNSSignificant Contract Wins
26th Jan 20157:00 amRNSFull Year Results
4th Dec 20147:00 amRNSSignificant Contract Win
1st Dec 20147:00 amRNSPre-close trading update
5th Nov 20147:00 amRNSDirector/PDMR Shareholding
16th Sep 20147:00 amRNSInterim Management Statement
23rd Jun 20147:00 amRNSInterim Results
5th Jun 20148:50 amRNSTotal Voting Rights
3rd Jun 20147:00 amRNSTrading Update
23rd Apr 201411:39 amRNSDirector Declaration
8th Apr 20144:20 pmRNSAGM resolutions
8th Apr 20147:00 amRNSAGM Statement and IMS
25th Feb 20147:00 amRNSAppointment of Non-Executive Director
3rd Feb 201410:08 amRNSDirector/PDMR Shareholding
27th Jan 20147:00 amRNSPreliminary Results
16th Jan 20144:07 pmRNSBlocklisting Application
4th Dec 20137:00 amRNSPre-close trading update
29th Nov 20134:02 pmRNSTotal Voting Rights
26th Sep 20137:00 amRNSAcquisition and Licensing agreement
25th Sep 20134:10 pmRNSDirector/PDMR Shareholding
17th Sep 20137:00 amRNSInterim Management Statement
7th Aug 20134:32 pmRNSHolding(s) in Company
6th Aug 20137:00 amRNSContract extension
15th Jul 201311:17 amRNSHolding(s) in Company
9th Jul 20135:13 pmRNSHolding(s) in Company
28th Jun 201312:25 pmRNSHolding(s) in Company
28th Jun 201312:19 pmRNSHolding(s) in Company
26th Jun 20137:00 amRNSDirectors' Shareholdings and Issue of Equity
24th Jun 20136:17 pmRNSHolding(s) in Company
24th Jun 20137:00 amRNSInterim Results
21st Jun 20139:02 amRNSBlocklisting application
5th Jun 20137:00 amRNSAcquisition and Trading Update
31st May 201312:01 pmRNSTotal Voting Rights
16th Apr 20134:02 pmRNSDirectors' Shareholdings and Issue of Equity
16th Apr 20132:39 pmRNSAGM resolutions and notice of filings
16th Apr 20137:00 amRNSAGM Statement, IMS and Contract extension
28th Feb 201310:00 amRNSTotal Voting Rights
13th Feb 20137:00 amRNSContract Win
5th Feb 20136:16 pmRNSHolding(s) in Company
5th Feb 20134:40 pmRNSHolding(s) in Company
28th Jan 201312:28 pmRNSBlocklisting Application
28th Jan 20137:00 amRNSResults for the year ended 30 November 2012
11th Jan 20137:00 amRNSContract Win
30th Nov 20128:48 amRNSHolding(s) in Company
29th Nov 201211:32 amRNSHolding(s) in Company
29th Nov 201210:29 amRNSDirector/PDMR Shareholding
28th Nov 20127:00 amRNSPre-close trading update
28th Sep 201212:34 pmRNSDirector/PDMR Shareholding
26th Sep 20127:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.